ExodusPoint Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Buy |
+19,149
| New | +$17K | ﹤0.01% | 1314 |
|
|
2023
Q2 | – | Sell |
-32,143
| Closed | -$48K | – | 1971 |
|
|
2023
Q1 | $48K | Buy |
+32,143
| New | +$48K | ﹤0.01% | 1572 |
|
|
2022
Q1 | – | Sell |
-12,142
| Closed | -$30K | – | 2387 |
|
|
2021
Q4 | $30K | Buy |
+12,142
| New | +$30K | ﹤0.01% | 2024 |
|
|
2021
Q2 | – | Sell |
-334,197
| Closed | -$785K | – | 2519 |
|
|
2021
Q1 | $785K | Sell |
334,197
-473,415
| -59% | -$1.11M | 0.01% | 1020 |
|
|
2020
Q4 | $1.42M | Buy |
807,612
+792,095
| +5,105% | +$1.39M | 0.01% | 640 |
|
|
2020
Q3 | $15K | Buy |
15,517
+2,293
| +17% | +$2.22K | ﹤0.01% | 1611 |
|
|
2020
Q2 | $12K | Buy |
+13,224
| New | +$12K | ﹤0.01% | 1690 |
|